午夜插插,噜噜噜影院,啪啪伊人网,欧美熟夫,景甜吻戏视频,男人强操性感蕾丝美女视频在线网站,日本美女跳舞视频

Nantong QuanYi Biotechnology Co., Ltd

Firmenname:Nantong QuanYi Biotechnology Co., Ltd
Telefon:0513-66337626
E-Mail:sales@chemhifuture.com
Nationalit?t:China
URL: https://www.chemhifuture.com/
Produkte insgesamt:5656
52 53 54 55 56 57

Produktkatalog

PF-063722221407592-99-7C26H28F3N5O3
3-(5-bromo-1H-indol-3-yl)-2,2-dimethylpropyl acetate2641451-61-6C15H18BrNO2
Mito-TRFSC38H34IN2O5PS2
rac-5-Methyl Tetrahydropteroic Acid Sodium Salt4349-41-1C15H18N6O3
Linustedastatum2254299-48-2C26H29F2N3O2
Fluotrimazol1-[Diphenyl[3-(trifluormethyl)phenyl]methyl]-1H-1,2,4-triazol31251-03-3C22H16F3N3
Dihydroxanthopterin1131-35-7C6H7N5O2
L18-MDP60398-08-5C37H66N4O12
tert-butyl 4-[5-bromo-6-[(1S)-1-methoxyethyl]pyridin-3-yl]piperazine-1-carboxylate2641824-76-0C17H26BrN3O3
Obatoclax803712-67-6C20H19N3O
(R)-2-(1-amino-2-(2,5-dibromophenyl)ethyl)-5-bromopheno1585969-24-9C14H12Br3NO
VT029562999763-09-4C22H23N5O
BMV1091458731-58-2C107H108F4N10O23S5
3-((5-Bromopyridin-2-yl)oxy)189954-65-2C18H16BrNO5S
Fenoterol hydrobromide5-[1-Hydroxy-2-[[2-(4-hydroxyphenyl)-1-methylethyl]amino]ethyl]resorcinhydrobromid1944-12-3C17H21NO4.BrH
Natalizumab189261-10-7C40H55N7O11S
Duvyzat497833-27-9C24H27N3O4
OG-L0021357302-64-7C15H15NO
Mitoquinol845959-55-9C38H49O7PS
Tezepelumab1572943-04-4
Trastuzumab Deruxtecan1826843-81-5N/A
Pembrolizumab (anti-PD-1)
Trastuzumab emtansine1018448-65-1
GNE75992771069-76-0C31H40N6O3S
ML307
11-cis Retinoic Acid68070-35-9C20H28O2
Ivonescimab2428381-53-5
Clerosterol2364-23-0C29H48O
ATR-IN-292761193-67-1C19H22N8O
3-[(2S)-2-amino-3-methylbutanamido]propane-1-sulfonic acid1034190-08-3C8H18N2O4S
AG-7404343565-99-1C26H29N5O7
(9s,10s)-9,10-Dihydro-9,10-[1,2]benzenoanthracene-1,4-diol5969-70-0C20H14O2
Colibactin 7422916559-62-9C37H42N8O5S2
KDOAM252230731-99-2C15H25N5O2
Glycerophosphoinositol choline425642-32-6C14H32NO12P
IPG-1 AM1369302-18-0C55H62Cl2N2O20
Quisinostat (JNJ-26481585)875320-29-9C21H26N6O2
iBFAR2353484-02-3C19H15F3N2O2
TRFS-red
Nicorandil Impurity 161157-74-0C10H12N4O7
Mepolizumab196078-29-2
Ocrelizumab637334-45-3C19H16N2O5
Dupliumab1190264-60-8
Tocilizumab375823-41-9C14H12O3
Pertuzumab380610-27-5C17H27NO2
AMrubicin hydrochloride92470-31-0C25H26ClNO9
Epitinib1203902-67-3C24H26N6O2
Sarilumab1189541-98-7
Benralizumab1044511-01-4
Aducanumab1384260-65-4
Efmoroctocog alfa1270012-79-7
Ramucirumab (anti-VEGFR)947687-13-0
Panitumumab339177-26-3
Casirivimab
Lecanemab1260393-98-3
Alemtuzumab216503-57-0
Benzoquinazolinone 121227923-91-2C28H27N5O2
DRF-1042200619-13-2C22H20N2O6
Emicizumab1610943-06-0
Cytochalasin D/Zygosporin A/NSC 2098357(S),18(R)-Dihydroxy-16(S),18-dimethyl-10-phenyl[11]cytochalasa-6(12),13(E),19(E)-trien-1,17-dion-21(R)-acetat22144-77-0C30H37NO6
(E)-2-Hydroxyoctadec-9-enoic acid56472-31-2
5-TMRIA [Tetramethylrhodamine-5-Iodoacetamide Dihydroiodide114458-99-0C26H24IN3O4
(R)-8-Cyclopentyl-2-((1-(2-((3R,5S)-3,5-dimethylpiperazin-1-yl)acetyl)-6-methoxyindolin-5-yl)amino)-7-ethyl-5-methyl-7,8-dihydropteridin-6(5H)-one3063893-60-4
Risankizumab
RP037073030493-05-8C55H58F3N11O4
Zurletrectinib/ICP-7232403703-30-8C19H19F2N7O2
Balomenib2939850-17-4C33H34F3N7O2
Thiamine Triphosphate3475-65-8C12H19N4O10P3S
Glycerylphosphorylcholine563-24-6C8H20NO6P
1110768-13-21110768-13-2C31H36Cl2N2O5S
STING agonist-292868261-51-0
ASP3082
Imdevimab
Abemaciclib metabolite M182704316-81-2C25H28F2N8O
Ledaborbactam etzadroxil1842399-68-1C19H26BNO7
SR 142948184162-64-9C39H51N5O6
BWC09772254567-00-3C22H21FN6O5
Elsibucol216167-95-2C35H54O4S2
2714410-97-42714410-97-4C28H23D5N2O11
ITK degrader 22858738-65-3
GDC-23942238822-08-5C20H25N5O4S.Na
23-Oxa-OSW-1790224-37-2C54H82O16
Menin-MLL inhibitor-222851841-61-5C29H39N7O3S
Epyrifenacil353292-31-6C21H16ClF4N3O6
GIP/GLP-1 dual receptor agonist-12807481-02-1
65141-56-265141-56-2C9H10N4O7
HRS-46422836263-09-1C34H35F3N6O3
RIBI-529216014-46-9C98H190N3O17P
KRASG12D-IN-33033638-63-7C31H30ClF6N7O2
AG-041R159883-95-1C31H36N4O5
Isoleucyl tRNA synthetase-IN-22494195-61-6C22H33N5O8S
DGN549-C2058075-34-4C60H61N9O12
PROTAC BTK Degrader-122736508-65-7C47H54N12O4
Anti-MouseVEGFR-2Antibody(DC101)
AUR-15453031593-79-7
Aleniglipron/GSBR-12902685823-26-9C49H55FN9O6P
Org 25543363628-88-0C24H32N2O4
KRASG12D-IN-3-d33033638-69-3C31H27ClD3F6N7O2
(S)-2-(((Benzyloxy)carbonyl)amino)-2-((tert-butoxycarbonyl)amino)acetic acid1932778-68-1C15H20N2O6
2'-chloro-5'-methoxy-6-methyl-[4,4'-bipyridine]-3-carboxylic acid2782812-46-6C13H11ClN2O3
52 53 54 55 56 57
Copyright 2019 ? ChemicalBook. All rights reserved